Furthermore, adoptive cellular therapy using chimeric antigen receptor (CAR) T cells targeting ICAM1 could effectively eliminate patient-derived anaplastic thyroid cancer cells which were overexpressing ICAM1 on their membrane in animal models (71). The gene discussed is ICAM1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.